Your Health, We Care
Anagrelide is indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.
FDA，2021.10
Anagrelide, as a platelet-reducing medication, plays an important role in the tr···【more】
Release date：2026-03-27Recommended：256
Anagrelide is used to reduce the platelet count in patients with myeloproliferat···【more】
Release date：2026-01-30Recommended：232
Thrombocythemia【more】
Release date：2026-01-05Recommended：195
LuciusVersionofAnagrelide:DosageandAdministration,Indications,PrecautionsIndicat···【more】
Release date：2025-12-02Recommended：267
Anagrelide is a drug used to treat thrombocythemia, primarily for abnormal eleva···【more】
Release date：2024-12-12Recommended：414
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
